Cogent Biosciences, Inc.
Cash Flow History
| Fiscal Year | Operating Cash Flow | Free Cash Flow | CapEx | Share-Based Compensation |
|---|---|---|---|---|
| FY2020 | $-35.9M | $-35.9M | — | $6.0M |
| FY2021 | $-58.8M | $-60.5M | $1.7M | $11.7M |
| FY2022 | $-118.6M | $-125.5M | $6.9M | $18.4M |
| FY2023 | $-153.6M | $-156.4M | $2.8M | $30.6M |
| FY2024 | $-207.8M | $-208.4M | $573.0K | $39.7M |